144 related articles for article (PubMed ID: 15639075)
1. Endometrial vascularization in levonorgestrel intrauterine device users; computerized microvessel measurement study.
Jondet M; Letellier B; Verdys MT
Contraception; 2005 Jan; 71(1):60-4. PubMed ID: 15639075
[TBL] [Abstract][Full Text] [Related]
2. Endometrial vessel maturation in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
Stéphanie R; Labied S; Blacher S; Frankenne F; Munaut C; Fridman V; Beliard A; Foidart JM; Nisolle M
Hum Reprod; 2007 Dec; 22(12):3084-91. PubMed ID: 17921480
[TBL] [Abstract][Full Text] [Related]
3. Differential elevation of matrix metalloproteinase expression in women exposed to levonorgestrel-releasing intrauterine system for a short or prolonged period of time.
Labied S; Galant C; Nisolle M; Ravet S; Munaut C; Marbaix E; Foidart JM; Frankenne F
Hum Reprod; 2009 Jan; 24(1):113-21. PubMed ID: 18812421
[TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factors and their receptors in human endometrium from women experiencing abnormal bleeding patterns after prolonged use of a levonorgestrel-releasing intrauterine system.
Möller B; Rönnerdag M; Wang G; Odlind V; Olovsson M
Hum Reprod; 2005 May; 20(5):1410-7. PubMed ID: 15760960
[TBL] [Abstract][Full Text] [Related]
5. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.
Hidalgo MM; Hidalgo-Regina C; Bahamondes MV; Monteiro I; Petta CA; Bahamondes L
Contraception; 2009 Jul; 80(1):84-9. PubMed ID: 19501221
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
[TBL] [Abstract][Full Text] [Related]
8. Endometrial effects of intrauterine levonorgestrel.
Guttinger A; Critchley HO
Contraception; 2007 Jun; 75(6 Suppl):S93-8. PubMed ID: 17531624
[TBL] [Abstract][Full Text] [Related]
9. Use of the levonorgestrel-releasing intrauterine system in breast cancer patients.
Trinh XB; Tjalma WA; Makar AP; Buytaert G; Weyler J; van Dam PA
Fertil Steril; 2008 Jul; 90(1):17-22. PubMed ID: 17706209
[TBL] [Abstract][Full Text] [Related]
10. Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium.
Gomes MK; Rosa-e-Silva JC; Garcia SB; de Sá Rosa-e-Silva AC; Turatti A; Vieira CS; Ferriani RA
Hum Reprod; 2009 Nov; 24(11):2736-45. PubMed ID: 19661125
[TBL] [Abstract][Full Text] [Related]
11. Correlation between endometrial histology, microvascular density and calibre, matrix metalloproteinase-3 and bleeding pattern in women using a levonorgestrel-releasing intrauterine system.
Oliveira-Ribeiro M; Petta CA; De Angelo Andrade LA; Bahamondes L; Hidalgo MM
Hum Reprod; 2004 Aug; 19(8):1778-84. PubMed ID: 15192067
[TBL] [Abstract][Full Text] [Related]
12. Intrauterine release of progesterone antagonist ZK230211 is feasible and results in novel endometrial effects: a pilot study.
Heikinheimo O; Vani S; Carpén O; Tapper A; Härkki P; Rutanen EM; Critchley H
Hum Reprod; 2007 Sep; 22(9):2515-22. PubMed ID: 17636280
[TBL] [Abstract][Full Text] [Related]
13. Endometrial chemokines, uterine natural killer cells and mast cells in long-term users of the levonorgestrel-releasing intrauterine system.
Peloggia A; Petta CA; Bahamondes L; Oliveira-Ribeiro M; Zhang J; Salamonsen L
Hum Reprod; 2006 May; 21(5):1129-34. PubMed ID: 16436495
[TBL] [Abstract][Full Text] [Related]
14. Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women.
Lehtovirta P; Paavonen J; Heikinheimo O
Contraception; 2007 Jan; 75(1):37-9. PubMed ID: 17161122
[TBL] [Abstract][Full Text] [Related]
15. [Effects of levonorgestrel-releasing intrauterine system on endometrial estrogen and progesterone receptors in patients with endometrial hyperplasia].
Weng M; Li L; Feng S; Xie M; Hong S
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1350-4. PubMed ID: 22985581
[TBL] [Abstract][Full Text] [Related]
16. The levonorgestrel-releasing intrauterine device induces endometrial decidualisation in women on tamoxifen.
Philip S; Taylor AH; Konje JC; Habiba M
J Obstet Gynaecol; 2019 Nov; 39(8):1117-1122. PubMed ID: 31195902
[TBL] [Abstract][Full Text] [Related]
17. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
Wildemeersch D; Janssens D; Andrade A
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
[TBL] [Abstract][Full Text] [Related]
18. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis.
Petta CA; Ferriani RA; Abrao MS; Hassan D; Rosa E Silva JC; Podgaec S; Bahamondes L
Hum Reprod; 2005 Jul; 20(7):1993-8. PubMed ID: 15790607
[TBL] [Abstract][Full Text] [Related]
19. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
Magalhães J; Aldrighi JM; de Lima GR
Contraception; 2007 Mar; 75(3):193-8. PubMed ID: 17303488
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy during the use of levonorgestrel intrauterine system.
Backman T; Rauramo I; Huhtala S; Koskenvuo M
Am J Obstet Gynecol; 2004 Jan; 190(1):50-4. PubMed ID: 14749634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
